Insider Trading November 12, 2026 11:31 AM

Amdocs Director Sarah Davis Buys $35,127 in Shares

Director's open-market purchase and grant come as Amdocs shares trade at $44.46, down 45% year-to-date.

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
DOX

Sarah R. Davis, a director at Amdocs Ltd. (NASDAQ:DOX), acquired 822 ordinary shares for $35,127 on November 9, 2026, at $42.7341 per share, and received 6,058 shares through a grant at no cost on the same date. Following these transactions, she directly holds 23,368 ordinary shares, including shares subject to outstanding restricted stock units. The insider purchase occurs as Amdocs shares trade at $44.46, down 45% year-to-date, though an analysis suggests the stock is undervalued. The company has been aggressively buying back shares and offers a 5.28% dividend yield. Amdocs reported fiscal 2026 revenue of $4.7 billion, up 3.6%, and non-GAAP EPS of $7.41, up 6%, in line with expectations. However, the company projected a decline in revenue and profit for fiscal 2027 due to a significant customer dispute with T-Mobile, leading Oppenheimer to downgrade the stock from Outperform to Perform. In the fiscal fourth quarter, Amdocs reported non-GAAP earnings of $1.98 per share and revenue of $1.19 billion, both meeting Wall Street's expectations.

Amdocs Director Sarah Davis Buys $35,127 in Shares
DOX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Director Sarah R. Davis bought 822 shares for $35,127 at $42.7341 per share and received 6,058 shares via a grant, bringing her direct holdings to 23,368 shares.
  • Amdocs shares trade at $44.46, down 45% year-to-date, but analysis suggests the stock is undervalued, with management aggressively buying back shares and a 5.28% dividend yield.
  • Fiscal 2026 revenue rose 3.6% to $4.7 billion and non-GAAP EPS increased 6% to $7.41, in line with expectations, but fiscal 2027 guidance projects declines due to a T-Mobile dispute, prompting an Oppenheimer downgrade.

Amdocs Ltd. (NASDAQ:DOX) director Sarah R. Davis acquired ordinary shares worth $35,127 on November 9, 2026, according to a regulatory filing. Davis purchased 822 shares at a price of $42.7341 per share. On the same date, she also acquired 6,058 ordinary shares through a grant at no cost. Following these transactions, Davis directly holds a total of 23,368 ordinary shares, a figure that includes ordinary shares subject to outstanding restricted stock units.

The insider purchase comes as Amdocs shares trade at $44.46, down 45% year-to-date. Despite the decline, an analysis suggests the stock is undervalued at current levels. According to available insights, management has been aggressively buying back shares, one of more than 12 exclusive insights available to subscribers. The company also offers a substantial 5.28% dividend yield.

In other recent news, Amdocs reported fiscal 2026 revenue of $4.7 billion, reflecting a 3.6% increase, and non-GAAP earnings per share of $7.41, marking a 6% rise. These figures were in line with expectations. However, the company has projected a decline in revenue and profit for fiscal 2027 due to a significant customer dispute with T-Mobile. This development has raised concerns among investors. Oppenheimer has downgraded Amdocs' stock rating from Outperform to Perform, citing the weak guidance for fiscal 2027 and the ongoing dispute with a major customer. In the fiscal fourth quarter, Amdocs reported non-GAAP earnings of $1.98 per share and revenue of $1.19 billion, both meeting Wall Street's expectations. Despite meeting these forecasts, the outlook for fiscal 2027 has drawn considerable attention. These recent developments have prompted analysts and investors to reassess their positions on Amdocs.

Amdocs shares were recently trading at $44.28, up $1.16 or 2.69%, on real-time data. The stock has a 52-week range that reflects the significant year-to-date decline. The company's dividend yield of 5.28% may appeal to income-focused investors, while the share buyback program signals management's confidence in the business.

The insider transaction provides a data point for investors tracking executive and director activity. Insider buying can offer insight into internal confidence, valuation perceptions, and potential inflection points. However, it is important to consider the broader context of the company's performance and outlook.

Amdocs provides software and services to communications and media companies. The company's fiscal 2026 results were in line with expectations, but the fiscal 2027 guidance reflects the impact of the T-Mobile dispute. Investors will be watching for further developments on this front and any additional insider transactions.

Risks

  • The significant customer dispute with T-Mobile could continue to pressure Amdocs' revenue and profit, particularly in the communications and media software sector.
  • The weak fiscal 2027 guidance and the Oppenheimer downgrade may lead to further analyst caution and investor uncertainty, affecting the stock's performance.
  • Insider buying does not guarantee positive future performance and should be considered alongside broader company fundamentals and market conditions.

More from Insider Trading

Aquestive Director Daly Discloses $99,330 Open-Market Share Purchase Nov 12, 2026 CNB Financial Director Gary Olson Offloads $904,750 in Stock Nov 12, 2026 OPENLANE Director Kestner Offloads $281,840 in Stock Nov 12, 2026 Japan Post Trust Trims Aflac Stake With $1.65 Million Share Sale Nov 12, 2026 Hornbeck Offshore CEO Todd Hornbeck Buys $1.5 Million in Company Stock Nov 12, 2026